Vericel Anticipates Strong Second Half for MACI
The company grew in the high-single digits in 2Q22, representing the highest MACI revenue total outside of fourth quarters since...
The company grew in the high-single digits in 2Q22, representing the highest MACI revenue total outside of fourth quarters since...
The company grew in the mid-single digits for 2Q22 as it benefitted from increased volume in newer product categories....
The company grew in the low single digits for 2Q22 despite market headwinds and raised its full-year 2022 guidance....
The company declined in the mid-single digits in 2Q22 as disruption in China exacerbated existing execution and supply problems....
The company grew in the double digits for 2Q22 with modest declines in the U.S. offset by strength in Europe,...
The company grew in the low single digits for 2Q22 as it contends with slower OUS markets and evolving dynamics...
The company's second-quarter sales declined in the low single digits as it faced a strong prior year comparison and OUS...
The company's renewed focus on competitiveness and market share paid off in its fiscal year 2022, as Medtronic grew in...
The company grew in the high single digits for 1Q22, driven by a company record for procedure volume in March....
The company grew in the high single digits for 1Q22 as its non-elective trauma business offset COVID-related elective procedure headwinds....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.